149 related articles for article (PubMed ID: 29791673)
1. Development of a clinical protocol for detection of cervical cancer precursor lesions.
Sousa DMDN; Chagas ACMA; Vasconcelos CTM; Stein AT; Oriá MOB
Rev Lat Am Enfermagem; 2018; 26():e2999. PubMed ID: 29791673
[TBL] [Abstract][Full Text] [Related]
2. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
3. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
[TBL] [Abstract][Full Text] [Related]
4. Detecting premalignant cervical lesions. Contribution of screening colposcopy to cytology.
Davison JM; Marty JJ
J Reprod Med; 1994 May; 39(5):388-92. PubMed ID: 8064706
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers for early detection of cervical neoplasia.
Unger ER; Steinau M; Rajeevan MS; Swan D; Lee DR; Vernon SD
Dis Markers; 2004; 20(2):103-16. PubMed ID: 15322318
[No Abstract] [Full Text] [Related]
6. The use of p16 as a marker for cervical cancer precursor lesions.
O'Connor DM
J Low Genit Tract Dis; 2007 Apr; 11(2):67-8. PubMed ID: 17415108
[No Abstract] [Full Text] [Related]
7. [Not Available].
Bode-Lesniewska B; Caduff R
Praxis (Bern 1994); 2017; 106(6):305-310. PubMed ID: 28300000
[No Abstract] [Full Text] [Related]
8. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
9. Guidelines in Low and Middle Income Countries Paper 3: Appraisal of Philippine Clinical Practice Guidelines using Appraisal of Guidelines for Research and Evaluation II: improvement needed for rigor, applicability, and editorial independence.
Dans LF; Salaveria-Imperial MLA; Miguel RTD; Tan-Lim CSC; Eubanas GAS; Tolosa MTS; Ho BLC; Silvestre MAA
J Clin Epidemiol; 2020 Nov; 127():184-190. PubMed ID: 32621853
[TBL] [Abstract][Full Text] [Related]
10. ASCUS diagnoses.
Frankel KA
Acta Cytol; 1998; 42(1):271-2. PubMed ID: 9479351
[No Abstract] [Full Text] [Related]
11. Preventing cervical cancer globally.
Schmeler KM
Cancer Prev Res (Phila); 2012 Nov; 5(11):1257-9. PubMed ID: 23129579
[TBL] [Abstract][Full Text] [Related]
12. [Precancerous lesions of the uterine cervix].
Purola E
Duodecim; 1985; 101(15):1496-503. PubMed ID: 4042903
[No Abstract] [Full Text] [Related]
13. [HPV TEST SCREENING FOR THE DETECTION OF PRECANCEROUS CERVICAL LESIONS AND CERVICAL CANCER].
Schejter E; Segal J
Harefuah; 2018 Nov; 157(11):704-706. PubMed ID: 30457233
[No Abstract] [Full Text] [Related]
14. Cervical precancerous lesions and cancer among patients in the gynaecology outpatient department at a tertiary hospital in South Africa.
Hank E; Hoque ME; Zungu L
Asian Pac J Cancer Prev; 2013; 14(8):4903-6. PubMed ID: 24083765
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of the Triple Test Versus Colposcopy for the Diagnosis of Premalignant and Malignant Cervical Lesions.
Fatahi Meybodi N; Karimi-Zarchi M; Allahqoli L; Sekhavat L; Gitas G; Rahmani A; Fallahi A; Hassanlouei B; Alkatout I
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3501-3507. PubMed ID: 33369445
[TBL] [Abstract][Full Text] [Related]
16. Eradication of cervical cancer in Latin America.
Bosch FX
Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
[No Abstract] [Full Text] [Related]
17. Improved national Croatian diagnostic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects.
Ljubojević N; Babić S; Audy-Jurković S; Ovanin-Rakić A; Jukić S; Babić D; Grubisić G; Radaković B; Ljubojević-Grgec D
Coll Antropol; 2001 Dec; 25(2):467-74. PubMed ID: 11811276
[TBL] [Abstract][Full Text] [Related]
18. Methodological Quality Appraisal of 27 Korean Guidelines Using a Scoring Guide Based on the AGREE II Instrument and a Web-based Evaluation.
Chang SG; Kim DI; Shin ES; Jang JE; Yeon JY; Lee YS
J Korean Med Sci; 2016 May; 31(5):682-7. PubMed ID: 27134487
[TBL] [Abstract][Full Text] [Related]
19. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
[No Abstract] [Full Text] [Related]
20. Treatment of precancerous lesions of the cervix in young women.
Diakomanolis E
Eur J Obstet Gynecol Reprod Biol; 1994 May; 55(1):26-7. PubMed ID: 7958134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
